Brian Corrigan - Aug 12, 2024 Form 4 Insider Report for LEXICON PHARMACEUTICALS, INC. (LXRX)

Role
SVP, Regulatory & QA
Signature
/s/ Brian T. Corrigan
Stock symbol
LXRX
Transactions as of
Aug 12, 2024
Transactions value $
$0
Form type
4
Date filed
8/12/2024, 08:40 AM

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction LXRX Stock Option (Right to Buy) Award $0 +200K $0.00 200K Aug 12, 2024 Common Stock 200K $1.60 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Option vests with respect to 25% of the shares subject to the option on the first anniversary of grant, and vests 1/48th per month for each month of service thereafter.